You are here: Industry Insights > Eli Lilly

News List

Lilly, Incyte Release Information on Baricitinib, Remdesivir Combination for COVID-19 americanpharmaceuticalreview
October 15, 2020
Eli Lilly and Company and Incyte are sharing additional data showing baricitinib in combination with remdesivir reduced time to recovery and improved clinical outcomes for patients with COVID-19 infection compared with remdesivir.
Lilly Provides Update on SARS-CoV-2 Neutralizing Antibody Programs americanpharmaceuticalreview
October 14, 2020
Eli Lilly and Company announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim data on combination therapy in recently diagnosed patients with mild-to-moderate COVID-19 – and plans to make these therapies ...
Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA® (Rituximab Injection) in China prnasia
October 10, 2020
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company ...
Eli Lilly seeks EUA for monotherapy against Covid-19 pharmaceutical-technology
October 10, 2020
Eli Lilly has submitted an application to the US Food and Drug Administration (FDA) seeking emergency use authorisation (EUA) for LY-CoV555 monotherapy for treating higher-risk patients with mild-to-moderate Covid-19.
BenevolentAI's Platform-Derived Hypothesis for COVID-19 Treatment Validated in NIAID Trial americanpharmaceuticalreview
September 22, 2020
BenevolentAI has confirmed data released from a large scale randomized clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), further validating its AI-derived hypothesis for baricitinib as a treatment for COVID-19
Lilly’s COVID-19 antibody shows promise in mid-stage study pharmatimes
September 18, 2020
Eli Lilly has reported interim analysis from a Phase II study of its antibody LY-CoV555 in mild-to-moderate recently diagnosed COVID-19 patients, and the data is promising.
Executive Moves at Lilly contractpharma
September 18, 2020
Patrik Jonsson will serve as senior vice president, president of Lilly USA, and Ilya Yuffa is promoted to senior vice president Lilly Bio-Medicines.
Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes expresspharma
September 07, 2020
The US Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company’s Trulicity (dulaglutide). The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11.
Eli Lilly expands Tyvyt collaboration with Innovent Biologics pharmaceutical-technology
August 20, 2020
Eli Lilly has agreed to a global expansion of its strategic collaboration with Innovent Biologics for Tyvyt (sintilimab injection), which the partners jointly develop in China.
Eli Lilly, Pieris collaborate on HER2-positive cancer clinical programme pharmatimes
August 12, 2020
Eli Lilly and Pieris Pharmaceuticals have entered into a clinical trial collaboration and supply agreement to evaluate a combination of candidates in multiple types of solid tumoirs, including HER2-positive tumours.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page